ORMAT TECHNOLOGIES INC (ORA) Stock Analyst Ratings
NYSE:ORA - New York Stock Exchange, Inc. - US6866881021 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 72% to ORA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 86.45. This target is 25.61% above the current price.
ORA was analyzed by 13 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about ORA.
In the previous month the buy percentage consensus was at a similar level.
ORA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-20 | Jefferies | Upgrade | Hold -> Buy |
| 2025-01-10 | Jefferies | Initiate | Hold |
| 2024-12-19 | Piper Sandler | Initiate | Neutral |
| 2024-11-08 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-11-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-12 | Roth MKM | Maintains | Buy -> Buy |
| 2024-08-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-06-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-14 | UBS | Maintains | Buy -> Buy |
| 2024-05-13 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-10 | TD Cowen | Maintains | Hold -> Hold |
| 2024-02-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-19 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-10-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-07 | Roth MKM | Upgrade | Neutral -> Buy |
| 2023-06-27 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-06-16 | Citigroup | Reiterate | Neutral -> Neutral |
| 2023-05-22 | Barclays | Initiate | Equal-Weight |
| 2023-05-11 | Roth MKM | Maintains | Neutral -> Neutral |
| 2023-05-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-03-27 | Citigroup | Maintains | Neutral |
| 2023-03-01 | UBS | Upgrade | Neutral -> Buy |
| 2023-02-27 | Roth MKM | Maintains | Neutral |
| 2023-02-24 | Oppenheimer | Maintains | Outperform |
| 2022-10-21 | Citigroup | Initiate | Neutral |
| 2022-10-20 | JP Morgan | Maintains | Neutral |
| 2022-08-08 | Oppenheimer | Maintains | Outperform |
| 2022-08-08 | JP Morgan | Maintains | Neutral |